Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myomo Inc.

0.9136
+0.04134.73%
Volume:790.94K
Turnover:718.19K
Market Cap:34.54M
PE:-3.70
High:0.9338
Open:0.8942
Low:0.8800
Close:0.8723
52wk High:7.17
52wk Low:0.8526
Shares:37.80M
Float Shares:33.12M
Volume Ratio:0.77
T/O Rate:2.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2468
EPS(LYR):-0.1638
ROE:-68.32%
ROA:-21.22%
PB:1.96
PE(LYR):-5.58

Loading ...

Company Profile

Company Name:
Myomo Inc.
Exchange:
AMEX
Establishment Date:
2004
Employees:
185
Office Location:
45 Blue Sky Dr.,Suite 101,Burlington,Massachusetts,United States
Zip Code:
01803
Fax:
- -
Introduction:
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Directors

Name
Position
Paul R. Gudonis
President, Chief Executive Officer and Chairman of the board
Amy Knapp
Director
Steve Sanghi
Director
Thomas A. Crowley, Jr.
Director
Thomas F. Kirk
Director

Shareholders

Name
Position
Paul R. Gudonis
President, Chief Executive Officer and Chairman of the board
Ralph A. Goldwasser
Chief Financial Officer
Davie Mendelsohn
Vice President - Sales and Clinical Services
Jonathan Naft
Vice President and General Manager